Results 51 to 60 of about 18,786 (126)

Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 7, July 2026.
Intratumoral bacteria are emerging as active regulators of cancer evolution rather than bystanders. This review outlines how tumor‐resident microbes drive tumor initiation and growth by inducing genomic instability, epigenetic reprogramming, oncogenic signaling, and chronic inflammation, while promoting metastatic spread via invasion, angiogenesis ...
Jiawei Chen, Yupan Bai, Lu Shen, Jiacheng Ying, Jie Xu, Jiayin Tang, Yujie Bao   +6 more
wiley   +1 more source

Auger electron-emitting EGFR-targeted and non-targeted [197Hg]Hg-gold nanoparticles for treatment of glioblastoma multiforme (GBM)

EJNMMI Radiopharmacy and Chemistry
Background We describe here radiation nanomedicines for glioblastoma multiforme (GBM) composed of gold nanoparticles (AuNPs) that integrate the Auger electron-emitter, 197Hg. [197Hg]Hg-AuNPs were conjugated to anti-epidermal growth factor receptor (EGFR)
Madeline K. Brown, Zhongli Cai, Constantine J. Georgiou, Shaohuang Chen, Yumeela Ganga-Sah, Valery Radchenko, James T. Rutka, Raymond M. Reilly   +7 more
doaj   +1 more source

Development of a Clinically Relevant Temozolomide-Resistant Human Glioblastoma A-172 Cell Line

Background: Glioblastoma is the most aggressive and deadly form of brain cancer, with a median survival of approximately 14 months. A major factor contributing to an unfavorable prognosis is the development of resistance to temozolomide (TMZ), the current first-line chemotherapeutic drug for glioblastoma. Thus, developing reliable preclinical models of
Pajović, Milica, Dinić, Jelena, Lupšić, Ema, Jovanović Stojanov, Sofija, Grozdanić, Marija, Pešić, Milica, Podolski-Renić, Ana, Dragoj, Miodrag   +7 more
openaire   +1 more source

Culture Dimensionality Modulates Gallium Maltolate Response in Glioblastoma: Comparative Analyses in 2D and 3D Models. [PDF]

Mol Pharm
Szeliska P, Jaroch K, Wróblewska W, Kaźmierski Ł, Maj M, Bojko B.   +5 more
europepmc   +1 more source

Receptor Binding, Functional Activity, and Cell Viability Assessment of Novel Marine-Based Hybrid Peptides from <i>Raja porosa</i>. [PDF]

Mar Drugs
Bauer M, Szeleszczuk Ł, Velmurugan BK, Chiang SL, Laskowska AK, Pisklak DM, Szűcs E, Gombos D, Kamysz W, Fehér T, Pielaszkiewicz N, Małek K, Kleczkowska P.   +12 more
europepmc   +1 more source

IRAK4 Regulates NF-κB signaling to suppress CD8 + T cell activity and promote immune evasion in glioblastoma development. [PDF]

Cancer Immunol Immunother
Xue Z, Song Z, Mo L, Shi L, Yang S.
europepmc   +1 more source

Correction: Glioblastoma induces CAF-like astrocyte activation via the AKT/mTOR-SERPINH1/COL5A1 axis. [PDF]

Biomol Biomed
Zhang J, Chen Y, Xu H.
europepmc   +1 more source

PARP Inhibitors as Radiosensitizers: Current Evidence and Future Directions. [PDF]

Curr Oncol Rep
Pereira E, Pereira F, Campos G, Abrantes AM, Botelho MF, Silva-Vaz P, Pires AS.   +6 more
europepmc   +1 more source

Myconanotechnology: evaluation of Ag-Cu bimetallic nanoparticles synthesized by Ganoderma aff. australe against pathogens and cancer cells. [PDF]

Int Microbiol
García-Villavicencio ER, Montiel-Lucio OW, Lira-Díaz E, Morales-Luckie RA, Sunny A, Burrola-Aguilar C, Estrada-Zúñiga ME, Díaz-Talamantes C, Zepeda-Gómez C, Fernández JJA, González-Pedroza MG.   +10 more
europepmc   +1 more source

Machine-Learning-Based Survival Prediction in Glioblastoma Using Graph-Theoretical Analysis of Structural Network Alterations. [PDF]

Cancers (Basel)
Stadlbauer A, Oberndorfer S, Heinz G, Marhold F, Kinfe TM, Dorostkar M, Schnell O, Meyer-Bäse U, Meyer-Bäse A.   +8 more
europepmc   +1 more source